Despite new restrictions looming, abortion pill use is rising in the US

In the United States, the use of medication for abortions has surged to 63% between 2020 and 2023, as revealed by analysis from the Guttmacher Institute. This increase, from 53% in 2020, underscores a growing reliance on medication rather than surgical procedures for terminating pregnancies, particularly since the FDA approved mifepristone in 2000. However, looming Supreme Court hearings threaten to restrict access to mifepristone, a commonly used abortion medication available via mail. Anti-abortion groups have pushed for bans on mail-order access, citing concerns about safety and legal time limits. The Guttmacher Institute emphasizes the importance of considering scientific evidence in the upcoming decision. Meanwhile, major pharmacy chains like Walgreens and CVS have announced plans to fill mifepristone prescriptions in states where abortion remains legal. This development comes amidst a backdrop of shifting abortion laws across states, with twenty-one states enacting tighter restrictions since the landmark Roe v Wade case.

News: Despite new restrictions looming, abortion pill use is rising in the US